menu
    • menu

    Company profile for PharmAla Biotech

    NEW Drugs in Dev: 2
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    PharmAla Biotech was formed by a devoted team of biomanufacturing, regulatory and financial professionals, driven by the belief that MDMA shows clinical promise as a treatment for numerous disorders. We believe that the only way to advance the scientific research directly related to the medicinal use of MDMA is to ensure that researchers have a steady and accessible supply of clinical grade Active Pharmaceutical Ingredient (AP...
    PharmAla Biotech was formed by a devoted team of biomanufacturing, regulatory and financial professionals, driven by the belief that MDMA shows clinical promise as a treatment for numerous disorders. We believe that the only way to advance the scientific research directly related to the medicinal use of MDMA is to ensure that researchers have a steady and accessible supply of clinical grade Active Pharmaceutical Ingredient (API).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PharmAla BiotechCanada Flag
    Country
    Country
    Canada
    Address
    Address
    82 Richmond St. E, Toronto, ON M5C 1P1
    Telephone
    Telephone
    1-855-444-MDMA (6362)
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://pharmala.ca/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PharmAla Inks Supply & Data Deal For Phase 2 MDMA Trial
    PharmAla Inks Supply & Data Deal For Phase 2 MDMA Trial

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248469/0/en/PharmAla-Signs-Supply-Data-Agreement-with-Nautilus-Sanctuary-for-Phase-2-MDMA-Clinical-Trial-Treating-Post-Traumatic-Stress-and-Adjustment-Disorder-in-Frontline-Healthcare-Workers-.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    PharmAla Inks Drug Donation Deal For Fibromyalgia MDMA Therapy
    PharmAla Inks Drug Donation Deal For Fibromyalgia MDMA Therapy

    26 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/26/3245567/0/en/PharmAla-Signs-Drug-Donation-Agreement-for-MDMA-Assisted-Therapy-Clinical-Trial-in-Fibromyalgia.html

    GLOBENEWSWIRE
    26 Feb 2026
    Share Share
    PharmAla To Supply Amsterdam UMC with LaNeo MDMA
    PharmAla To Supply Amsterdam UMC with LaNeo MDMA

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3242630/0/en/PharmAla-To-Supply-Amsterdam-UMC-with-LaNeo-MDMA-Including-Development-of-New-Single-Capsule-Stability-Data.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share
    PharmAla Announces Changes To Board Of Directors
    PharmAla Announces Changes To Board Of Directors

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235820/0/en/PharmAla-Announces-Changes-to-Board-of-Directors.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    Pharmala Partners With Østfold Hospital Trust For Laneo MDMA
    Pharmala Partners With Østfold Hospital Trust For Laneo MDMA

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215388/0/en/PharmAla-To-Supply-%C3%98stfold-Hospital-Trust-with-LaNeo-MDMA-for-Clinical-Research.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Pharmala Releases Audited 2025, Unaudited Q1 2026 Financials
    Pharmala Releases Audited 2025, Unaudited Q1 2026 Financials

    24 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/24/3210316/0/en/PharmAla-Issues-Audited-Year-End-2025-and-Unaudited-Q1-Fiscal-2026-Financial-Statements.html

    GLOBENEWSWIRE
    24 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search